IL146659A0 - Porous drug matrices and method of manufacture thereof - Google Patents
Porous drug matrices and method of manufacture thereofInfo
- Publication number
- IL146659A0 IL146659A0 IL14665900A IL14665900A IL146659A0 IL 146659 A0 IL146659 A0 IL 146659A0 IL 14665900 A IL14665900 A IL 14665900A IL 14665900 A IL14665900 A IL 14665900A IL 146659 A0 IL146659 A0 IL 146659A0
- Authority
- IL
- Israel
- Prior art keywords
- drug
- porous matrix
- forming agent
- pore forming
- volatile
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13632399P | 1999-05-27 | 1999-05-27 | |
US15865999P | 1999-10-08 | 1999-10-08 | |
US09/433,486 US6395300B1 (en) | 1999-05-27 | 1999-11-04 | Porous drug matrices and methods of manufacture thereof |
US18631000P | 2000-03-02 | 2000-03-02 | |
PCT/US2000/014578 WO2000072827A2 (en) | 1999-05-27 | 2000-05-25 | Porous drug matrices and methods of manufacture thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146659A0 true IL146659A0 (en) | 2002-07-25 |
Family
ID=27495210
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14665900A IL146659A0 (en) | 1999-05-27 | 2000-05-25 | Porous drug matrices and method of manufacture thereof |
IL146659A IL146659A (en) | 1999-05-27 | 2001-11-21 | Methods for preparing a porous matrix of drug |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL146659A IL146659A (en) | 1999-05-27 | 2001-11-21 | Methods for preparing a porous matrix of drug |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1180020B2 (ja) |
JP (1) | JP4722295B2 (ja) |
KR (2) | KR100883477B1 (ja) |
CN (1) | CN1240373C (ja) |
AT (1) | ATE312601T1 (ja) |
AU (1) | AU768022B2 (ja) |
BR (1) | BR0010984A (ja) |
CA (1) | CA2371836C (ja) |
DE (1) | DE60024811T3 (ja) |
DK (1) | DK1180020T4 (ja) |
ES (1) | ES2250141T5 (ja) |
HK (2) | HK1048956B (ja) |
IL (2) | IL146659A0 (ja) |
MX (1) | MXPA01012106A (ja) |
NO (1) | NO323761B1 (ja) |
NZ (1) | NZ516083A (ja) |
TW (1) | TWI274589B (ja) |
WO (1) | WO2000072827A2 (ja) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6342533B1 (en) | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
EP1905757A1 (en) | 1999-04-06 | 2008-04-02 | Sepracor Inc. | Derivatives of Venlafaxine and methods of preparing and using the same |
US8771740B2 (en) * | 1999-12-20 | 2014-07-08 | Nicholas J. Kerkhof | Process for producing nanoparticles by spray drying |
MY120279A (en) | 2000-05-26 | 2005-09-30 | Pharmacia Corp | Use of a celecoxib composition for fast pain relief |
US6589557B2 (en) * | 2000-06-15 | 2003-07-08 | Acusphere, Inc. | Porous celecoxib matrices and methods of manufacture thereof |
US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
DE10059020A1 (de) * | 2000-11-28 | 2002-05-29 | Gruenenthal Gmbh | Parenteral applizierbare Darreichungsformen |
EP1343372A2 (en) | 2000-12-21 | 2003-09-17 | Nektar Therapeutics | Pulmonary delivery of polyene antifungal agents |
US7115565B2 (en) | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
EP1365759A2 (en) * | 2001-01-18 | 2003-12-03 | PHARMACIA & UPJOHN COMPANY | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
US6673838B2 (en) † | 2001-02-12 | 2004-01-06 | Wyeth | Succinate salt of O-desmethyl-venlafaxine |
WO2002094231A1 (en) * | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of analgesics through an inhalation route |
US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
JP2005503425A (ja) | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | 所定の吸入ルートによる薬剤エステルの送出 |
US7105178B2 (en) | 2001-07-17 | 2006-09-12 | Sun Pharmaceutical Industries Limited | Cardiotonic composition |
WO2003041693A1 (en) * | 2001-11-09 | 2003-05-22 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
US7005138B2 (en) * | 2001-12-21 | 2006-02-28 | Duramed Pharmaceuticals, Inc. | Method of systematically delivering SSRIs |
ES2609482T3 (es) | 2002-03-20 | 2017-04-20 | Civitas Therapeutics, Inc. | Administración pulmonar de levodopa |
JP4452970B2 (ja) * | 2002-03-27 | 2010-04-21 | 日本臓器製薬株式会社 | ジクロフェナクナトリウム経口製剤 |
US7785627B2 (en) | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7959946B2 (en) | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US8980870B2 (en) | 2002-09-24 | 2015-03-17 | Boehringer Ingelheim International Gmbh | Solid telmisartan pharmaceutical formulations |
CA2500065A1 (en) * | 2002-09-30 | 2004-04-15 | Acusphere, Inc. | Sustained release porous microparticles for inhalation |
PL1610791T3 (pl) | 2003-03-31 | 2011-07-29 | Titan Pharmaceuticals Inc | Wszczepialne urządzenie polimerowe do przedłużonego uwalniania agonisty dopaminy |
CA2526478A1 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same |
GB0401947D0 (en) | 2004-01-28 | 2004-03-03 | Unilever Plc | Porous bodies and method of production thereof |
KR100681660B1 (ko) * | 2004-03-17 | 2007-02-09 | 주식회사종근당 | 방출제어 펠릿의 약제학적 조성물 |
GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
EP1681056A1 (en) | 2005-01-14 | 2006-07-19 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for preparing lansoprazole |
WO2007004236A2 (en) * | 2005-07-04 | 2007-01-11 | Ramu Krishnan | Improved drug or pharmaceutical compounds and a preparation thereof |
GB0517688D0 (en) * | 2005-08-31 | 2005-10-05 | Cambridge Biostability Ltd | Improvements in the stabilisation of biological materials |
GB0523638D0 (en) | 2005-11-21 | 2005-12-28 | Cambridge Biostability Ltd | Pharmaceutical device for the administration of substances to patients |
AR054215A1 (es) * | 2006-01-20 | 2007-06-13 | Eriochem Sa | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
JP2009524646A (ja) * | 2006-01-27 | 2009-07-02 | ザ・プロヴォスト,フェローズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホーリー・アンド・アンディヴァイデッド・トリニティー・オブ・クイーン・エリザベス,ニア・ダブリン | 多孔性微粒子の製造方法 |
KR100917809B1 (ko) | 2006-05-22 | 2009-09-18 | 에스케이케미칼주식회사 | 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물 |
GB0613925D0 (en) * | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
EP2121088B1 (en) | 2007-03-09 | 2016-07-13 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
KR101574354B1 (ko) * | 2007-04-27 | 2015-12-04 | 엔도 파마슈티컬즈, 솔루션스 아이엔씨. | 이식 장치 이형제 및 이의 사용 방법 |
PT103743B (pt) * | 2007-05-16 | 2013-01-15 | Hovione Farmaciencia S A | Processo para preparar derivados de 21-disódio fosfato de pregnanos. |
MX2010002179A (es) | 2007-08-24 | 2010-04-27 | Stichting Het Nl Kanker I | Composicion para el tratamiento de enfermedades neoplasicas. |
GB0716591D0 (en) * | 2007-08-24 | 2007-10-03 | Vereniging Het Nl Kanker I | Composition |
CN101888829A (zh) * | 2007-10-09 | 2010-11-17 | 诺瓦提斯公司 | 缬沙坦的药物制剂 |
US9801818B2 (en) | 2007-12-31 | 2017-10-31 | Samyang Biopharmaceuticals Corporation | Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug |
KR101024742B1 (ko) * | 2007-12-31 | 2011-03-24 | 주식회사 삼양사 | 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법 |
WO2010009492A1 (en) * | 2008-07-25 | 2010-01-28 | Alphapharm Pty Ltd | ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 μM TO ABOUT 10 μM |
JP2012500788A (ja) * | 2008-08-22 | 2012-01-12 | スティヒティング ヘット ネーデルランド カンケル インスティテュート | 組成物 |
US8685458B2 (en) | 2009-03-05 | 2014-04-01 | Bend Research, Inc. | Pharmaceutical compositions of dextran polymer derivatives |
ES2873502T3 (es) | 2009-03-27 | 2021-11-03 | Bend Res Inc | Proceso de secado por pulverización |
PT2611529T (pt) | 2010-09-03 | 2019-05-09 | Bend Res Inc | Método de secagem por pulverização |
PT2611530T (pt) | 2010-09-03 | 2019-05-09 | Bend Res Inc | Aparelho de secagem por pulverização e métodos de utilização do mesmo |
WO2012040502A1 (en) | 2010-09-24 | 2012-03-29 | Bend Research, Inc. | High-temperature spray drying process and apparatus |
RU2013139247A (ru) | 2011-02-23 | 2015-03-27 | Церулеус Лтд. | Комплексы флумазенила, содержащие их композиции и их применения |
US9060938B2 (en) | 2011-05-10 | 2015-06-23 | Bend Research, Inc. | Pharmaceutical compositions of active agents and cationic dextran polymer derivatives |
CN103301095B (zh) * | 2012-03-13 | 2016-04-13 | 中国科学院上海药物研究所 | 一种用于提高普罗布考口服吸收的多孔复合载药组合物及其制备方法 |
WO2013188926A1 (en) * | 2012-06-22 | 2013-12-27 | The University Of Queensland | Method and composition for delivering a compound through a biological barrier |
WO2015089105A1 (en) | 2013-12-09 | 2015-06-18 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
HUE061928T2 (hu) * | 2014-06-11 | 2023-09-28 | SpecGx LLC | Különbözõ oldódási profillal rendelkezõ porlasztva szárított készítmények és elõállításukhoz szükséges eljárások |
EP3212169B1 (en) | 2014-10-31 | 2021-01-13 | Bend Research, Inc. | Process for forming active domains dispersed in a matrix |
AU2015364280A1 (en) * | 2014-12-18 | 2017-07-06 | Windgap Medical, Inc. | Method and compositions for dissolving or solubilizing therapeutic agents |
JP6921759B2 (ja) | 2015-06-04 | 2021-08-18 | クリティテック・インコーポレイテッド | 捕集装置および使用法 |
RU2018113280A (ru) | 2015-09-16 | 2019-10-16 | ДиЭфБи СОРИА, ЭлЭлСи | Доставка наночастиц лекарственного средства и способы их использования |
RU2737934C2 (ru) | 2016-04-04 | 2020-12-07 | Крититек, Инк. | Способы лечения солидных опухолей |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
KR101965708B1 (ko) * | 2016-08-30 | 2019-04-04 | 이화여자대학교 산학협력단 | 스폰지 유사 구조를 갖는 고분자 미립자 및 이의 제조방법 |
WO2018170196A1 (en) | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes |
SG11201909840TA (en) | 2017-06-09 | 2019-11-28 | Crititech Inc | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
AU2018284247B2 (en) | 2017-06-14 | 2020-04-30 | Crititech Inc. | Methods for treating lung disorders |
RU2020110399A (ru) | 2017-10-03 | 2021-11-09 | Крититек, Инк. | Местная доставка противоопухолевых частиц в комбинации с системной доставкой иммунотерапевтических агентов для лечения рака |
BR112020013750A8 (pt) | 2018-01-05 | 2022-10-18 | Impel Neuropharma Inc | Dispensação intranasal de olanzapina por dispositivo olfativo de precisão |
US11497726B2 (en) | 2018-03-16 | 2022-11-15 | Dfb Soria, Ll. | Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes |
EP3917493A1 (en) * | 2019-01-29 | 2021-12-08 | Bayer HealthCare, LLC | Topical gel compositions of naproxen |
CN114269816B (zh) * | 2019-05-10 | 2023-09-19 | 阿诺米拉公司 | 多孔纤维素微粒及其制备方法 |
JP2023553202A (ja) | 2020-12-08 | 2023-12-20 | ルミナント バイオテク コーポレーション リミテッド | 動物に物質を送達するための装置および方法の改善 |
CN113081971A (zh) * | 2021-05-14 | 2021-07-09 | 江西中医药大学 | 一种中药多孔核壳型复合粒子粉体及其制备方法和应用 |
CN117538462B (zh) * | 2024-01-10 | 2024-03-26 | 地奥集团成都药业股份有限公司 | 一种氨氯地平贝那普利胶囊有关物质的检测方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1265615A (ja) * | 1970-09-10 | 1972-03-01 | ||
NL7313626A (nl) † | 1973-10-04 | 1975-04-08 | Philips Nv | Gecombineerde inrichting voor het produceren en sselen van warmte met een warmte ver- ende inrichting. |
GB8322007D0 (en) † | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
IL82245A (en) * | 1986-04-25 | 1990-07-26 | Basf Ag | Preparation of spray-dried granules of active ingredients |
EP0655237A1 (de) * | 1993-11-27 | 1995-05-31 | Hoechst Aktiengesellschaft | Medizinische Aerosolformulierung |
US5762961A (en) * | 1996-02-09 | 1998-06-09 | Quadrant Holdings Cambridge Ltd. | Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
CA2277801C (en) * | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
EP1019023B1 (en) * | 1997-09-29 | 2003-05-07 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in nebulizers |
JP4758525B2 (ja) * | 1998-03-20 | 2011-08-31 | 武田薬品工業株式会社 | 生理活性ポリペプチドの徐放性製剤およびその製造法 |
US6423345B2 (en) * | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
-
2000
- 2000-05-25 AU AU54459/00A patent/AU768022B2/en not_active Ceased
- 2000-05-25 KR KR1020077012286A patent/KR100883477B1/ko not_active IP Right Cessation
- 2000-05-25 CN CNB008081611A patent/CN1240373C/zh not_active Expired - Fee Related
- 2000-05-25 JP JP2000620939A patent/JP4722295B2/ja not_active Expired - Fee Related
- 2000-05-25 ES ES00939365T patent/ES2250141T5/es not_active Expired - Lifetime
- 2000-05-25 AT AT00939365T patent/ATE312601T1/de active
- 2000-05-25 NZ NZ516083A patent/NZ516083A/en not_active IP Right Cessation
- 2000-05-25 IL IL14665900A patent/IL146659A0/xx unknown
- 2000-05-25 DE DE60024811T patent/DE60024811T3/de not_active Expired - Lifetime
- 2000-05-25 EP EP00939365A patent/EP1180020B2/en not_active Expired - Lifetime
- 2000-05-25 WO PCT/US2000/014578 patent/WO2000072827A2/en not_active Application Discontinuation
- 2000-05-25 DK DK00939365T patent/DK1180020T4/da active
- 2000-05-25 BR BR0010984-3A patent/BR0010984A/pt not_active IP Right Cessation
- 2000-05-25 MX MXPA01012106A patent/MXPA01012106A/es active IP Right Grant
- 2000-05-25 CA CA002371836A patent/CA2371836C/en not_active Expired - Fee Related
- 2000-05-25 KR KR1020017015052A patent/KR100752000B1/ko not_active IP Right Cessation
- 2000-05-29 TW TW089110363A patent/TWI274589B/zh not_active IP Right Cessation
-
2001
- 2001-11-21 IL IL146659A patent/IL146659A/en not_active IP Right Cessation
- 2001-11-26 NO NO20015753A patent/NO323761B1/no not_active IP Right Cessation
-
2003
- 2003-02-20 HK HK03101310.8A patent/HK1048956B/zh not_active IP Right Cessation
-
2007
- 2007-02-27 HK HK07102209A patent/HK1094775A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146659A0 (en) | Porous drug matrices and method of manufacture thereof | |
RU2420290C2 (ru) | Твердые, пригодные для орального употребления фармацевтические формы применения, содержащие ривароксабан с модифицированным высвобождением | |
CA2430288C (en) | A composition improved in the solubility or oral absorbability | |
WO2001095877A3 (en) | Porous celecoxib matrices and methods of manufacture thereof | |
JP2000229846A (ja) | 放出制御型剤形 | |
ATE77946T1 (de) | Injizierbares langwirkendes mikroteilchenpr|parat zur verabreichung entzuendungshemmender mittel. | |
EP1295595A4 (en) | TABLET RAPIDLY DISINTEGRATING IN THE MOUTH AND CORRESPONDING PRODUCTION PROCESS | |
JPS58116414A (ja) | ニカルジピン持続性製剤用球形顆粒およびその製造法 | |
JP2000256195A (ja) | ニフェジピン小丸薬およびニフェジピン小丸薬の調製方法 | |
JP4401778B2 (ja) | 超臨界流体を用いて活性物質と多孔質支持体とを相互反応させた物質の製造方法 | |
AU2003235156B2 (en) | Solid dispersion composition | |
TH78112B (th) | เนื้อสารยารูพรุน และวิธีการของการผลิตของสิ่งเหล่านั้น | |
TH78112A (th) | เนื้อสารยารูพรุน และวิธีการของการผลิตของสิ่งเหล่านั้น | |
Minocha et al. | SOlubility enhancement of poorly water soluble drugs by various techniques | |
KR100981750B1 (ko) | 분무-건조 과립 및 그의 제조방법 | |
JP2616946B2 (ja) | 肝類洞小孔拡張・増加剤 | |
OGiso et al. | ABSORPTION AND BIOAVAILABILITY OF CALCIUM AND MAGNESIUM SALTS OF INDOMETHACIN FROM RECTAL SUPPOSITO-RIES | |
CN104887722A (zh) | 溶解性和安全性增强的银杏达莫注射剂及制备方法和应用 | |
JP2005298472A (ja) | イトラコナゾールを含む経口投与用組成物 | |
EP0323762A1 (fr) | Nouvelles compositions anti-tussives et leur procédé d'obtention | |
JPH07291863A (ja) | 腎保護作用剤 | |
Harindran | ENHANCEMENT OF BIOA DIFFERENT SOLUBILIT TECHNIQUES | |
KR20040105182A (ko) | 난용성 약물의 서방형 정제 | |
WO2011007838A1 (ja) | ベンズイミダゾール系注射剤 |